Chapter 11. Peroxisome Proliferator-Activated Receptor γ Modulation for the Treatment of Type 2 Diabetes

  1. Prof. Dr. Eckhard Ottow3 and
  2. Dr. Hilmar Weinmann4
  1. Alan M. Warshawsky1 and
  2. Anne Reifel Miller2

Published Online: 19 DEC 2008

DOI: 10.1002/9783527623297.ch11

Nuclear Receptors as Drug Targets

Nuclear Receptors as Drug Targets

How to Cite

Warshawsky, A. M. and Miller, A. R. (2008) Peroxisome Proliferator-Activated Receptor γ Modulation for the Treatment of Type 2 Diabetes, in Nuclear Receptors as Drug Targets (eds E. Ottow and H. Weinmann), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany. doi: 10.1002/9783527623297.ch11

Editor Information

  1. 3

    Bayer Schering Pharma AG, Medicinal Chemistry (S106/345), Müllerstrasse 178, 13342 Berlin, Germany

  2. 4

    Bayer Schering Pharma AG, Medicinal Chemistry (S106/048A), Müllerstrasse 178, 13342 Berlin, Germany

Author Information

  1. 1

    Eli Lilly & Co., Lilly Research Laboratories, Discovery Chemistry Research, Indianapolis, IN 46285, USA

  2. 2

    Eli Lilly & Co., Lilly Research Laboratories, Diabetes Research Division, Indianapolis, IN 46285, USA

Publication History

  1. Published Online: 19 DEC 2008
  2. Published Print: 20 AUG 2008

Book Series:

  1. Methods and Principles in Medicinal Chemistry

Book Series Editors:

  1. Prof. Dr. Raimund Mannhold5,
  2. Prof. Dr. Hugo Kubinyi6 and
  3. Prof. Dr. Gerd Folkers7

Series Editor Information

  1. 5

    Molecular Drug Research Group, Heinrich-Heine-Universität, Universitätsstrasse 1, 40225 Düsseldorf, Germany

  2. 6

    Donnersbergerstrasse 9, 67256 Weisenheim am Sand, Germany

  3. 7

    Collegium Helveticum, STW/ETH Zurich, 8092 Zurich, Switzerland

ISBN Information

Print ISBN: 9783527318728

Online ISBN: 9783527623297

SEARCH

Keywords:

  • peroxisome proliferator-activated receptor γ;
  • type 2 diabetes

Summary

This chapter contains sections titled:

  • Introduction

  • Currently Marketed PPARγ Ligands

  • Approaches to Improve PPARγ Activity

  • Discussion and Summary

  • Future Direction

  • References